secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001140361-25-000337
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.03, 8.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Bio secures additional $11.5M from PIPE closing and CIRM grant; cash runway into 2026
--------------------------------------------------------------------------------

- Closed subsequent PIPE closing with Celadon Partners for additional ~$10M gross proceeds (4,444 Series A shares + warrants for 6,666,000 common shares); total PIPE now $47.6M.
- Received $1.5M from CIRM grant; total received $6.4M of $8M grant announced June 2024.
- Cash runway guidance extended into 2026; proceeds to fund SENTI-202 development and manufacturing.
- Securities sold under Section 4(a)(2)/Rule 506 exemption; registration rights agreement for resale filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000114036125000337/0001140361-25-000337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000114036125000337/ef20040800_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-000337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer